IPMK modulates insulin-mediated suppression of hepatic glucose production
暂无分享,去创建一个
R. Ahima | Frederick Anokye-Danso | Sangwon F. Kim | Ik-Rak Jung | Frederick Anokye‐Danso | Sunghee Jin
[1] S. Snyder,et al. Loss of PI3k activity of inositol polyphosphate multikinase impairs PDK1-mediated AKT activation, cell migration, and intestinal homeostasis , 2020, bioRxiv.
[2] Seyun Kim,et al. Inositol polyphosphate multikinase in adipocytes is dispensable for regulating energy metabolism and whole-body metabolic homeostasis. , 2020, American journal of physiology. Endocrinology and metabolism.
[3] Yup Kang,et al. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice , 2019, Scientific Reports.
[4] P. Hamet,et al. Environmental and genetic contributions to diabetes. , 2019, Metabolism: clinical and experimental.
[5] F. White,et al. High‐fat diet in a mouse insulin‐resistant model induces widespread rewiring of the phosphotyrosine signaling network , 2019, Molecular systems biology.
[6] S. Snyder,et al. IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration , 2019, Cell reports.
[7] P. Puigserver,et al. Insulin regulation of gluconeogenesis , 2018, Annals of the New York Academy of Sciences.
[8] G. Shulman,et al. Regulation of hepatic glucose metabolism in health and disease , 2017, Nature Reviews Endocrinology.
[9] M. Birnbaum,et al. Unraveling the Regulation of Hepatic Metabolism by Insulin , 2017, Trends in Endocrinology & Metabolism.
[10] Yup Kang,et al. Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice , 2016, Scientific Reports.
[11] Z. Ye,et al. ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy. , 2016, Molecular cell.
[12] Eunha Kim,et al. IPMK: A versatile regulator of nuclear signaling events. , 2016, Advances in biological regulation.
[13] R. Ahima,et al. The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. , 2016, Cell reports.
[14] M. Birnbaum,et al. Hepatic Insulin Signaling is Dispensable for Suppression of Glucose Output by Insulin in Vivo , 2015, Nature Communications.
[15] I. Lucki,et al. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice , 2014, Neurobiology of Disease.
[16] R. Ahima,et al. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action. , 2014, Molecular endocrinology.
[17] S. Koo,et al. CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis , 2013, BMB reports.
[18] R. Tyagi,et al. Inositol polyphosphate multikinase is a coactivator for serum response factor-dependent induction of immediate early genes , 2013, Proceedings of the National Academy of Sciences.
[19] N. Sen,et al. Inositol polyphosphate multikinase is a transcriptional coactivator required for immediate early gene induction , 2013, Proceedings of the National Academy of Sciences.
[20] J. Florez,et al. Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes , 2013, Diabetes Care.
[21] F. Wondisford,et al. Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis* , 2012, The Journal of Biological Chemistry.
[22] E. Nagata,et al. Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death , 2012, Proceedings of the National Academy of Sciences.
[23] C. Kahn,et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.
[24] S. Snyder,et al. AMP-activated protein kinase is physiologically regulated by inositol polyphosphate multikinase , 2011, Proceedings of the National Academy of Sciences.
[25] D. Accili,et al. Hormonal regulation of hepatic glucose production in health and disease. , 2011, Cell metabolism.
[26] M. Montminy,et al. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals , 2011, Nature Reviews Molecular Cell Biology.
[27] Michael A. Koldobskiy,et al. Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. , 2011, Cell metabolism.
[28] S. Snyder,et al. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB , 2011, Proceedings of the National Academy of Sciences.
[29] R. Rizza. Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy , 2010, Diabetes.
[30] P. Roach,et al. Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo , 2010, Diabetes.
[31] R. DePinho,et al. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.
[32] R. DePinho,et al. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.
[33] M. Montminy,et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism , 2005, Nature.
[34] S. Snyder,et al. Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] B. Hogan,et al. An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Kahn,et al. Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.
[37] Y. Kido,et al. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue , 1998, Nature Genetics.